Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V On The Active Ingredient Natalizumab Ilo
Contract notice: conclusion of non-exclusive discount agreements according to § 130a para. 8 sgb v on the active ingredient natalizumab ilo §130a para. 8 sgb v enables the health insurance companies (kk) and pharmaceutical companies to conclude framework discount agreements on the pharmaceuticals
Chemical Tenders, Disposable Medical - Surgical Items Tenders, Drug Tenders